{"product_id":"cedars-sinai-6th-annual-cedars-sinai-gastrointestinal-tumor-conference-2025","title":"Cedars Sinai 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2025","description":"\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"os-singlevideo-title os-channel-title\"\u003e\n\u003ch3\u003eCedars Sinai 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2025\u003c\/h3\u003e\n\u003cstrong\u003e Include: 1 video + 11 pdf, size: 3.32 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: gastroenterologists, oncologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003eDate \u0026amp; Location: Saturday, April 5, 2025, 7:30 AM – 1:00 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Endocrinology \u0026amp; Metabolism, Family \/ General Medicine, Gastroenterology, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology \u0026amp; Laboratory Medicine, Radiation Oncology, Radiology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Occupational Therapist, Other (non-physician), Pharmacist, Physician, Researcher (non-physician)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThe 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastricesophagus.\u003cbr\u003e\u003cbr\u003eInvited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities.\u003cbr\u003e\u003cbr\u003eJoin your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eAnalyze advances in biomarkers and therapies to evaluate and synthesize treatment options for patients with gastroesophageal cancers.\u003c\/li\u003e\n\u003cli\u003eUse AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence based national guidelines for treatment planning\u003c\/li\u003e\n\u003cli\u003eEvaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside\u003c\/li\u003e\n\u003cli\u003eIncrease knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies\u003c\/li\u003e\n\u003cli\u003eIdentify and implement optimal strategies for managing therapy related side effects and toxicities in patients treated with therapeutic agents\u003c\/li\u003e\n\u003cli\u003eAnticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003eThe \u003cstrong\u003e6th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2025\u003c\/strong\u003e is tailored for a multidisciplinary group of healthcare professionals, with a strong focus on physicians involved in gastrointestinal cancer care. The target physician specialties include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eGastroenterology\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOncology\u003c\/strong\u003e (especially GI oncology)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRadiation oncology\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePathology and laboratory medicine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEndocrinology \u0026amp; metabolism\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFamily and general medicine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMedical genetics\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNuclear medicine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePain management and palliative care\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRadiology\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe conference emphasizes precision medicine, immunotherapy, and biomarker strategies for cancers of the pancreas, liver, and gastroesophagus. It’s a valuable opportunity for physicians to gain cutting-edge insights and apply them directly to clinical decision-making\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eApril 5 Full Live.mp4\u003cbr\u003eAgenda.pdf\u003cbr\u003eCedars Sinai Health System.pdf\u003cbr\u003eHow I treat liver metastases (surgical).pdf\u003cbr\u003eMolecular Landscape in CRC- Shaping the Future.pdf\u003cbr\u003eOvercoming obstacles to optimize care in Neuroendocrine tumors.pdf\u003cbr\u003eSocial Media in Oncology.pdf\u003cbr\u003eTargeting KRAS in GI malignancies.pdf\u003cbr\u003eThe Challenges of Treating Pancreatic Cancer.pdf\u003cbr\u003eUpdate in Surgical Management of Pancreatic Cancer.pdf\u003cbr\u003eUpdates on the Management of Gastric Cancer.pdf\u003cbr\u003eWelcome and Introduction.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e* Detail:\u003cbr\u003e\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, April 5, 2025\u003c\/h3\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDisclosure and Accredidation Information\u003c\/strong\u003e\u003cbr\u003e7:30AM – 7:40AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRegistration Check In and Exhibits\u003c\/strong\u003e\u003cbr\u003e7:30AM – 8:00AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRecording\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome and Introduction\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:05AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCedars Sinai Health System\u003c\/strong\u003e\u003cbr\u003e8:05AM – 8:25AM\u003cbr\u003eDavid Hoffman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTargeting KRAS in GI malignancies\u003c\/strong\u003e\u003cbr\u003e8:25AM – 8:45AM\u003cbr\u003eIgnacio Garrido-Laguna, MD, PhD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMolecular Landscape in CRC: Shaping the Future\u003c\/strong\u003e\u003cbr\u003e8:45AM – 9:05AM\u003cbr\u003eJason A. Zell, DO, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdates on the Management of Gastric Cancer\u003c\/strong\u003e\u003cbr\u003e9:05AM – 9:25AM\u003cbr\u003eDani Castillo, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe Challenges of Treating Pancreatic Cancer\u003c\/strong\u003e\u003cbr\u003e9:25AM – 9:45AM\u003cbr\u003eVincent J. Picozzi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate in Surgical Management of Pancreatic Cancer\u003c\/strong\u003e\u003cbr\u003e9:45AM – 10:05AM\u003cbr\u003eNicholas Nissen, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBreak and Exhibits\u003c\/strong\u003e\u003cbr\u003e10:05AM – 10:25AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: GI Cancer Cases\u003c\/strong\u003e\u003cbr\u003e10:25AM – 10:45AM\u003cbr\u003eKambiz Kosari, MD\u003cbr\u003eKatelyn Atkins, MD, PhD\u003cbr\u003eJeremy Lorber, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHow I treat liver metastases (surgical)\u003c\/strong\u003e\u003cbr\u003e10:45AM – 11:05AM\u003cbr\u003eAlexandra Gangi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOvercoming obstacles to optimize care in Neuroendocrine tumors\u003c\/strong\u003e\u003cbr\u003e11:05AM – 11:25AM\u003cbr\u003eEmily Bergsland, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePick Up Lunch and Exhibits\u003c\/strong\u003e\u003cbr\u003e11:25AM – 11:45AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSocial Media in Oncology\u003c\/strong\u003e\u003cbr\u003e11:45AM – 12:05PM\u003cbr\u003eSumanta Pal, MD, FASCO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClosing Remarks\u003c\/strong\u003e\u003cbr\u003e12:05PM – 12:15PM\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954490773602,"sku":"MED-AMB04442","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cedars-Sinai-6th-Annual-Cedars-Sinai-Gastrointestinal-Tumor-Conference-2025-scaled-1.jpg?v=1779377867","url":"https:\/\/meducourse.com\/products\/cedars-sinai-6th-annual-cedars-sinai-gastrointestinal-tumor-conference-2025","provider":"Meducourse","version":"1.0","type":"link"}